Share
Journal Information
Issue
Vol. 38. Issue 3.Pages 141-208 (April 2014)
Editorial
Urology and Web predictive resources
Á. Borque, M. Espárrago, F. Sánchez-Martín, J. Rubio-Briones, L.M. Esteban, G. Sanz
Actas Urol Esp. 2014;38:141-2
Original articles
Gene expression profiles in prostate cancer: Identification of candidate non-invasive diagnostic markers
L. Mengual, E. Ars, J.J. Lozano, M. Burset, L. Izquierdo, M. Ingelmo-Torres, J.M. Gaya, F. Algaba, ... A. Alcaraz
Actas Urol Esp. 2014;38:143-9
Diagnostic and predictive value of urine PCA3 gene expression for the clinical management of patients with altered prostate-specific antigen
N. Rodón, I. Trías, M. Verdú, R. Román, A. Domínguez, M. Calvo, J.M. Banus, A.M. Ballesta, ... X. Puig
Actas Urol Esp. 2014;38:150-5
Therapeutic benefit in patients switching tolterodine to other novel antimuscarinic agents
F. Sánchez-Ballester, P. Miranda, I. Lizarraga, J. Rejas, D. Arumi
Actas Urol Esp. 2014;38:156-63
Second transurethral resection and prognosis of high-grade non-muscle invasive bladder cancer in patients not receiving Bacillus Calmette-Guérin
J.C. Angulo, J. Palou, A. García-Tello, F.R. de Fata, O. Rodríguez, H. Villavicencio
Actas Urol Esp. 2014;38:164-71
Matrix metallopeptidase 2 (MMP2) mediates MHC class I polypeptide-related sequence A (MICA) shedding in renal cell carcinoma
F.Q. Yang, M. Liu, F.P. Yang, X.L. Zhang, B. Yang, C.C. Guo, J.H. Huang, J.P. Che, ... J.H. Zheng
Actas Urol Esp. 2014;38:172-8
Erectile dysfunction, metabolic syndrome and arterial disease. Clinical–pathological relation by carotid ultrasonography
M.A. Arrabal-Polo, B. Vera-Arroyo, C. Lahoz-García, P. Valderrama-Illana, M. Cámara-Ortega, M. Arrabal-Martín, A. Zuluaga-Gomez, F. Lopez-Carmona Pintado
Actas Urol Esp. 2014;38:179-83
Chemotherapy plus estramustine for management of castration-resistant prostate cancer: Meta-analysis of randomized controlled trials
C. Zhang, T. Jing, F. Wang, X. Gao, C. Xu, Y. Sun
Actas Urol Esp. 2014;38:184-91
Review article
Involvement of HLA class I molecules in the immune escape of urologic tumors
R. Carretero, H. Gil-Julio, F. Vázquez-Alonso, F. Garrido, J. Castiñeiras, J.M. Cózar
Actas Urol Esp. 2014;38:192-9
Skill and talent
Laparoscopic cystectomy and intracorporeal continent urinary diversion (Mainz II) in treatment for interstitial cystitis
O.A. Castillo, N. Miranda-Utrera
Actas Urol Esp. 2014;38:200-4
Letters to the editor
Laparoscopic distal ureterectomy for urothelial carcinoma is technically feasible… But is it oncologically safe?
J.M. Gaya, J. Palou
Actas Urol Esp. 2014;38:205-6
Response to comments on: Laparoscopic distal ureterectomy for urothelial carcinoma is technically feasible… But is it oncologically safe?
A. Garcia-Segui, F. Cáceres, J.C. Angulo
Actas Urol Esp. 2014;38:206-7
Publish in
Actas Urológicas Españolas
Special content about COVID-19
- Association between COVID-19 and increased incidence of overactive bladder symptoms in female patients: A retrospective analysis
- Water vapor thermal therapy: Technical variations among spanish hospitals and efficacy at 2-year follow-up
- Clinical impact of the suspension of the ERAS protocol on patients undergoing radical cystectomy during the COVID-19 pandemic
- External validation of the current scoring systems and derivation of a novel scoring system to predict stone free rates after retrograde intrarenal surgery in patients with cumulative stone diameter of 2–4 cm
Actas Urológicas Españolas (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.
www.publicationethics.org.